CRESEMBA caps 40 mg 35 pce

7680661720023 CH-66172 J02AC05 08.06.0.
CRESEMBA caps 40 mg 35 pce
CRESEMBA caps 40 mg 35 pce
CRESEMBA caps 40 mg 35 pce
1 / 3
google

Details

Product number
6617202
CPT
-
Packaging group
35
Unit
Kapsel(n)
Composition
isavuconazonium 40 mg ut isavuconazonii sulfas, magnesii citras, cellulosum microcristallinum, talcum, silica colloidalis anhydrica, acidum stearicum, Kapselhülle: hypromellosum, E 172 (rubrum), E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula.

Articles (1)

Cresemba 40 mg, Hartkapseln
Kapseln
35
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
25/04/2026
Patient information leaflet
Français
25/04/2026
Patient information leaflet
Italien
25/04/2026
Professional SmPC
Allemand
25/04/2026
Professional SmPC
Français
25/04/2026
Professional SmPC
Italien
25/04/2026

Detailed composition

Substance Quantity Type Category
isavuconazonium
40.0 MG Substance Wirkstoff (Principe actif)
isavuconazonii sulfas
- Substance WIZUS
magnesii citras
- Substance HIMDK
cellulosum microcristallinum
- Substance HNIDK
talcum
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
acidum stearicum
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK
E 171
- Substance FNIDK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammoniae solutio concentrata
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 781.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2025

Authorization holder

Basilea Pharmaceutica

4123 Allschwil

Authorization information

Swissmedic authorization number
66172
Drug name
Cresemba, Hartkapseln
Galenic form
KAHA
ATC Code
J02AC05
Authorization status
Z
Dispensation category
A
First authorization
20/10/2017
Authorization expiration date
31/12/9999
IT number
08.06.0.
Domain
Human medicine
Field of application
Antimykotikum

Packaging details

Description (FR)
CRESEMBA caps 40 mg 35 pce
Description (DE)
CRESEMBA Kaps 40 mg 35 Stk
Market launch
03/07/2025
Narcotic (BTM)
No

Other packaging sizes

CRESEMBA caps 100 mg 14 pce
14 KAP
View
Buy us a coffee Explore the data